11-Dodecynoic acid, also known as **undecylenic acid**, is a **fatty acid** with a triple bond at the 11th carbon atom. It is a colorless, oily liquid with a faint odor.
**Why is it important for research?**
11-Dodecynoic acid has several properties that make it useful for research in various fields:
**1. Antimicrobial activity:** It exhibits **antifungal** and **antibacterial** properties. This makes it a potential candidate for the development of new antifungal and antibacterial agents.
**2. Anti-inflammatory activity:** Studies have shown that 11-dodecynoic acid has **anti-inflammatory properties**. It may be helpful in treating inflammatory conditions like arthritis and inflammatory bowel disease.
**3. Anti-cancer activity:** Some research suggests that 11-dodecynoic acid may have **anti-cancer activity**. It has been shown to inhibit the growth of certain cancer cell lines.
**4. Biocompatibility:** It is generally considered to be **biocompatible**, making it suitable for use in biomedical applications like drug delivery systems and biomaterials.
**5. Chemical synthesis:** The presence of the triple bond makes it a useful building block for the synthesis of various organic compounds.
**Specific research areas where 11-dodecynoic acid is being investigated:**
* **Developing new antifungal drugs:** Its strong antifungal activity is being explored to treat fungal infections.
* **Investigating its potential as an anti-inflammatory agent:** Researchers are studying its effectiveness in treating various inflammatory conditions.
* **Exploring its anti-cancer properties:** Its ability to inhibit cancer cell growth is being investigated for its potential in cancer treatment.
* **Developing new drug delivery systems:** Its biocompatibility makes it suitable for use in drug delivery systems, particularly for targeting specific cells or tissues.
**Overall, 11-dodecynoic acid's unique properties and potential therapeutic applications make it a valuable tool for research in various fields, including medicine, pharmaceutical chemistry, and materials science.**
**Note:** It's important to remember that research is ongoing, and while 11-dodecynoic acid shows promise, its effectiveness and safety in specific applications still need further investigation.
11-dodecynoic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 152196 |
CHEBI ID | 195921 |
SCHEMBL ID | 1050169 |
MeSH ID | M0121618 |
Synonym |
---|
11-dodecynoic acid |
LMFA01030474 |
CHEBI:195921 |
dodec-11-ynoic acid |
16900-60-0 |
SCHEMBL1050169 |
DTXSID40168638 |
AT21759 |
LCZC1164 |
EN300-7493734 |
Class | Description |
---|---|
medium-chain fatty acid | Any fatty acid with a chain length of between C6 and C12. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.25) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |